PMID- 26060380
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150610
LR  - 20201001
IS  - 1061-1711 (Print)
IS  - 1615-5939 (Electronic)
IS  - 1061-1711 (Linking)
VI  - 24
IP  - 2
DP  - 2015 Jun
TI  - Percutaneous Transcatheter Closure of Ruptured Sinus of Valsalva Aneurysm: 
      Immediate Result and Long-Term Follow-Up.
PG  - 99-104
LID - 10.1055/s-0034-1396948 [doi]
AB  - There is scarcity of data on closure and long-term follow-up of percutaneous 
      treatment of ruptured sinus of Valsalva aneurysm (RSOVA). In this article, we 
      present our experience in percutaneous closure of this defect. Between December 
      2009 and July 2014, 11 cases of RSOVA were referred to our hospital. Eight of the 
      11 cases (72.7%) were considered for percutaneous closure. Seven of the eight 
      (87.5%) patients underwent successful percutaneous closure. There were four 
      females and three males in the age group of 16 to 48 years (mean 24.7 +/- 6.1 
      years). Associated defects were bicuspid aortic valve in one patient, mild 
      preexisting aortic regurgitation in two patients, and healed infective 
      endocarditis in one patient. Echocardiography revealed RSOVA from right coronary 
      sinus (RCS) to right atrium (RA) in one patient (14.3%), RCS to right ventricular 
      outflow in three patients (42.8%), and noncoronary sinus ruptured into RA in 
      three patients (42.8%). All patients were symptomatic in New York Heart 
      Association (NYHA) class II to IV. The defect size ranged from 7 to 10 mm (mean 
      8.4 +/- 1.3 mm). The defects were closed from the venous side with device selection 
      2 to 4 mm higher than the defect size under fluoroscopy and transesophageal 
      echocardiography guidance. Technical success was 87.5%. The mean device size was 
      12.0 +/- 1.6 mm/10.0 +/- 1.6 mm. Six out of seven patients (85.7%) had complete 
      disappearance of shunt before discharge. During 1 to 55 months follow-up, all 
      patients were in NYHA class I. There was no residual shunt, progression of AR or 
      new AR, infective endocarditis or device embolization. Percutaneous closure of 
      RSOVA appears to be a safe alternative to surgical therapy, with high technical 
      success and excellent long-term outcome.
FAU - Sinha, Sudhir Chandra
AU  - Sinha SC
AD  - Department of Cardiology, Indus Hospitals, Visakhapatnam, India.
FAU - Sujatha, Vipperla
AU  - Sujatha V
AD  - Department of Cardiology, Indus Hospitals, Visakhapatnam, India.
FAU - Mahapatro, Anil Kumar
AU  - Mahapatro AK
AD  - Department of Cardiology, Indus Hospitals, Visakhapatnam, India.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Angiol
JT  - The International journal of angiology : official publication of the 
      International College of Angiology, Inc
JID - 9504821
PMC - PMC4452606
OTO - NOTNLM
OT  - aneurysm
OT  - cardiac catheterization
OT  - cardiac device
OT  - cardiac surgery
OT  - endocarditis
OT  - endovascular procedure
OT  - percutaneous
EDAT- 2015/06/11 06:00
MHDA- 2015/06/11 06:01
PMCR- 2016/06/01
CRDT- 2015/06/11 06:00
PHST- 2015/06/11 06:00 [entrez]
PHST- 2015/06/11 06:00 [pubmed]
PHST- 2015/06/11 06:01 [medline]
PHST- 2016/06/01 00:00 [pmc-release]
AID - 140100 [pii]
AID - 10.1055/s-0034-1396948 [doi]
PST - ppublish
SO  - Int J Angiol. 2015 Jun;24(2):99-104. doi: 10.1055/s-0034-1396948.